TAK-881 Clinical Trials
2 recruitingBiologic
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda59 enrolled52 locationsNCT06747351
Recruiting
Phase 3
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
Primary Immunodeficiency Diseases (PID)
Takeda39 enrolled5 locationsNCT06076642